108 related articles for article (PubMed ID: 25838370)
1. Immunology. MULT1plying cancer immunity.
Steinle A; Cerwenka A
Science; 2015 Apr; 348(6230):45-6. PubMed ID: 25838370
[No Abstract] [Full Text] [Related]
2. Immunotherapy: Soluble ligands--a new approach to cancer therapy.
Errico A
Nat Rev Clin Oncol; 2015 Jun; 12(6):311. PubMed ID: 25801813
[No Abstract] [Full Text] [Related]
3. Shed NKG2D ligand boosts NK cell immunity.
Narni-Mancinelli E; Vivier E
Cell Res; 2015 Jun; 25(6):651-2. PubMed ID: 25849247
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms of tumor resistance to NK killing: of mice and men.
Pardoll DM
Immunity; 2015 Apr; 42(4):605-6. PubMed ID: 25902479
[TBL] [Abstract][Full Text] [Related]
5. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
Deng W; Gowen BG; Zhang L; Wang L; Lau S; Iannello A; Xu J; Rovis TL; Xiong N; Raulet DH
Science; 2015 Apr; 348(6230):136-9. PubMed ID: 25745066
[TBL] [Abstract][Full Text] [Related]
6. NKG2D-MICA Interaction: A Paradigm Shift in Innate Recognition.
Bléry M; Vivier E
J Immunol; 2018 Apr; 200(7):2229-2230. PubMed ID: 29555675
[No Abstract] [Full Text] [Related]
7. New twist on the regulation of NKG2D ligand expression.
Cerwenka A
J Exp Med; 2009 Feb; 206(2):265-8. PubMed ID: 19204110
[TBL] [Abstract][Full Text] [Related]
8. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
Diefenbach A; Hsia JK; Hsiung MY; Raulet DH
Eur J Immunol; 2003 Feb; 33(2):381-91. PubMed ID: 12645935
[TBL] [Abstract][Full Text] [Related]
9. Increasing polymorphism of the RAET1E/ULBP4 gene in humans.
Pearson H; Madrigal JA; Saudemont A; Cox ST
HLA; 2016 Jan; 87(1):63-5. PubMed ID: 26814419
[TBL] [Abstract][Full Text] [Related]
10. Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma.
Belting L; Hömberg N; Przewoznik M; Brenner C; Riedel T; Flatley A; Polić B; Busch DH; Röcken M; Mocikat R
Eur J Immunol; 2015 Sep; 45(9):2593-601. PubMed ID: 26151313
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D; Rivera P; Marcenaro S; Chang CC; Biassoni R; Conte R; Kubin M; Cosman D; Ferrone S; Moretta L; Moretta A
Cancer Res; 2002 Nov; 62(21):6178-86. PubMed ID: 12414645
[TBL] [Abstract][Full Text] [Related]
12. Three novel allelic variants of the RAET1E/ULBP4 gene in humans.
Cox ST; Madrigal JA; Saudemont A
Tissue Antigens; 2012 Oct; 80(4):390-2. PubMed ID: 22845659
[TBL] [Abstract][Full Text] [Related]
13. Pillars Article: Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA.
Bauer S; Groh V; Wu J; Steinle A; Phillips JH; Lanier LL; Spies T
J Immunol; 2018 Apr; 200(7):2231-2233. PubMed ID: 29555676
[No Abstract] [Full Text] [Related]
14. MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
Tietje A; Li J; Yu X; Wei Y
Gene Ther; 2014 May; 21(5):468-75. PubMed ID: 24572784
[TBL] [Abstract][Full Text] [Related]
15. The role of microRNAs in the control of innate immune response in cancer.
Jasinski-Bergner S; Mandelboim O; Seliger B
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217579
[TBL] [Abstract][Full Text] [Related]
16. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
[TBL] [Abstract][Full Text] [Related]
17. Activation of natural killer cells: underlying molecular mechanisms revealed.
Backström E; Kristensson K; Ljunggren HG
Scand J Immunol; 2004; 60(1-2):14-22. PubMed ID: 15238069
[TBL] [Abstract][Full Text] [Related]
18. SHIP1 intrinsically regulates NK cell signaling and education, resulting in tolerance of an MHC class I-mismatched bone marrow graft in mice.
Gumbleton M; Vivier E; Kerr WG
J Immunol; 2015 Mar; 194(6):2847-54. PubMed ID: 25687756
[TBL] [Abstract][Full Text] [Related]
19. MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions.
Campbell AR; Duggan MC; Suarez-Kelly LP; Bhave N; Opheim KS; McMichael EL; Trikha P; Parihar R; Luedke E; Lewis A; Yung B; Lee R; Raulet D; Tridandapani S; Groh V; Yu L; Yildiz V; Byrd JC; Caligiuri MA; Carson WE
Cancer Immunol Res; 2017 Sep; 5(9):778-789. PubMed ID: 28724544
[TBL] [Abstract][Full Text] [Related]
20. [B7-H6 : a novel alert signal for NK cells].
Baratin M; Vivier E
Med Sci (Paris); 2010 Feb; 26(2):119-20. PubMed ID: 20188033
[No Abstract] [Full Text] [Related]
[Next] [New Search]
